Cannabinoid Type 1 Receptor Antagonism Delays Ascites Formation in Rats With Cirrhosis
Authors:
- Mauro BernardiMBMauro Bernardi
- 1 July 2009
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 137 (1) , 341-349
Abstract
No abstract availableKeywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Sanofi
- Fondazione Cassa di Risparmio di Civitavecchia
This publication has 25 references indexed in Scilit:
- Endocannabinoids acting at CB1receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Portal hypertension and its complicationsCurrent Opinion in Gastroenterology, 2007
- Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB1 and VR1 receptorsBritish Journal of Pharmacology, 2006
- Differential mechanisms mediating depressor and diuretic effects of anandamideJournal Of Hypertension, 2006
- The Endocannabinoid System as an Emerging Target of PharmacotherapyPharmacological Reviews, 2006
- Cannabinoid receptors and endocannabinoids: Evidence for new playersThe AAPS Journal, 2006
- A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosisJournal of Hepatology, 2005
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorFEBS Letters, 1994
- Carbon tetrachloride induced cirrhosis in rats: A useful tool for investigating the pathogenesis of ascites in chronic liver diseaseJournal of Gastroenterology and Hepatology, 1992
- Temporal Relationship Between Hyperaldosteronism, Sodium Retention and Ascites Formation in Rats With Experimental CirrhosisHepatology, 1985